170 related articles for article (PubMed ID: 24276413)
1. Almost a tragedy: severe methotrexate toxicity in a hemodialysis patient treated for ectopic pregnancy.
Willner N; Storch S; Tadmor T; Schiff E
Eur J Clin Pharmacol; 2014 Mar; 70(3):261-3. PubMed ID: 24276413
[TBL] [Abstract][Full Text] [Related]
2. Pancytopenia, mucositis, and hepatotoxicity after intralesional methotrexate injection in a patient treated with peritoneal dialysis.
Flynn KN; Johnson MS; Brink WC; Smith DL
Am J Health Syst Pharm; 2012 Apr; 69(7):578-82. PubMed ID: 22441788
[TBL] [Abstract][Full Text] [Related]
3. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
[TBL] [Abstract][Full Text] [Related]
4. Low-dose methotrexate-induced vulvar edema: A case report.
Jia G; Chai W; He Z; Liu X; Wen Y; Cui L; Gong F
Medicine (Baltimore); 2019 Aug; 98(35):e16895. PubMed ID: 31464920
[TBL] [Abstract][Full Text] [Related]
5. Pancytopenia after low dose methotrexate therapy in a hemodialysis patient: case report and review of literature.
Yang CP; Kuo MC; Guh JY; Chen HC
Ren Fail; 2006; 28(1):95-7. PubMed ID: 16526326
[TBL] [Abstract][Full Text] [Related]
6. Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer.
Cheng KK
Eur J Cancer Care (Engl); 2008 May; 17(3):306-11. PubMed ID: 18419635
[TBL] [Abstract][Full Text] [Related]
7. Fatal methotrexate toxicity in a patient treated for an ectopic pregnancy.
Gaïes E; Ben Sassi M; Charfi R; Lakhal M; Klouz A; Trabelsi S; Salouage I
Therapie; 2016 Jun; 71(3):348-50. PubMed ID: 27235664
[No Abstract] [Full Text] [Related]
8. [Delayed elimination of methotrexate after high-dose infusion].
Kuleva SA
Vopr Onkol; 2013; 59(1):126-31. PubMed ID: 23814840
[No Abstract] [Full Text] [Related]
9. [Successful treatment of high-dose methotrexate-induced oliguric acute renal failure by using a combination of hemodialysis filtration and direct hemoperfusion].
Morozumi I; Inagaki A; Suzuki S; Sato Y; Ogura H; Suga N; Komatsu H; Wakita A; Yamada K
Gan To Kagaku Ryoho; 2015 May; 42(5):609-11. PubMed ID: 25981656
[TBL] [Abstract][Full Text] [Related]
10. Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction.
Shafie M; Abbaszadeh M; Sharifi F
Daru; 2021 Jun; 29(1):205-209. PubMed ID: 33409982
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate-induced Severe Pancytopenia in a Patient with Rheumatoid Arthritis: A Case Report and Review of Literature.
Hosseini E; Shahbazi F
Curr Drug Saf; 2024; 19(2):224-235. PubMed ID: 37194235
[TBL] [Abstract][Full Text] [Related]
12. Genetics of high-dose methotrexate-induced oral mucositis: current perspectives.
Heil SG
Pharmacogenomics; 2019 Jun; 20(9):621-623. PubMed ID: 31250729
[No Abstract] [Full Text] [Related]
13. Severe pancytopenia in a patient taking low dose methotrexate and probenecid.
Basin KS; Escalante A; Beardmore TD
J Rheumatol; 1991 Apr; 18(4):609-10. PubMed ID: 2066953
[TBL] [Abstract][Full Text] [Related]
14. Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia.
den Hoed MA; Lopez-Lopez E; te Winkel ML; Tissing W; de Rooij JD; Gutierrez-Camino A; Garcia-Orad A; den Boer E; Pieters R; Pluijm SM; de Jonge R; van den Heuvel-Eibrink MM
Pharmacogenomics J; 2015 Jun; 15(3):248-54. PubMed ID: 25348617
[TBL] [Abstract][Full Text] [Related]
15. Understanding and managing methotrexate nephrotoxicity.
Widemann BC; Adamson PC
Oncologist; 2006 Jun; 11(6):694-703. PubMed ID: 16794248
[TBL] [Abstract][Full Text] [Related]
16. High-dose methotrexate-induced fulminant hepatic failure and pancytopenia in an acute lymphoblastic leukaemia paediatric patient.
Sajith M; Pawar A; Bafna V; Bartakke S
Eur J Hosp Pharm; 2020 May; 27(3):178-180. PubMed ID: 32419940
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-induced toxidermia and pancytopenia in a patient with ectopic pregnancy: a case report.
Refeno V; Rasamimanana NG; Abasse BA; Ramarokoto MPM; Fanomezantsoa MJE; Randaoharison PG
J Med Case Rep; 2021 Dec; 15(1):579. PubMed ID: 34872594
[TBL] [Abstract][Full Text] [Related]
18. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
Calvo-Romero JM
Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
Gilani ST; Khan DA; Khan FA; Ahmed M
J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
[TBL] [Abstract][Full Text] [Related]
20. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
Cecyn KZ; Lee J; Oguro T; Petrilli AS; Bordin JO
Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]